A Revolution in Immunotherapy for Cervical an...

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

‏التالي

ASCO26 Preview: Novel Therapies and Innovations in Cancer Care

Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

. 23 دقيقة و54 ثانية

The Future of AI in Oncology: A Conversation With Google's AI Innovators

Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical ... عرض المزيد

. 27 دقيقة و23 ثانية

‏حلقات موصى بها

Treatment of Metastatic Colorectal Cancer Guideline

ASCO Guidelines

An interview with Dr. Van Morris from The University of Texas MD Anderson Cancer Center in Houston, TX and Dr. Cathy Eng from Vanderbilt-Ingram Cancer Center in Nashville, TN, co-chairs on "Treatment of Metastatic Colorectal Cancer: ASCO Guideline." Dr. Morris and Dr. Eng review ... عرض المزيد

. 21 دقيقة و12 ثانية

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline

ASCO Guidelines

Dr. Praveen Vikas, Dr. Tyler Johnson, and Dr. Russell Broaddus present the ASCO endorsement of the Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Associa ... عرض المزيد

. 16 دقيقة و31 ثانية

Targeted Therapy and Immunotherapy for Gastroesophageal Cancer Guideline

ASCO Guidelines

Dr. Manish Shah discusses the first ASCO guideline for advanced gastroesophageal cancer. He addresses biomarker testing to help guide therapy - including HER2 testing, mismatch repair testing, and assessment of PD-L1 expression. Dr. Shah then reviews the evidence-based recommenda ... عرض المزيد

. 13 دقيقة و32 ثانية

Endocrine and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer – Capivasertib-Fulvestrant: Rapid Guideline Update

ASCO Guidelines

Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein present the latest breast cancer rapid recommendation update impacting two ASCO guidelines. This update focuses on the new option, capivasertib plus fulvestrant, for patients with hormone receptor-positive, HER2-negati ... عرض المزيد

. 14 دقيقة و9 ثانية